A person was diagnosed this Monday, January 6, as a carrier of the clade 1b subvariant of the mpox virus in France. This is a novelty in French territory, while the vast majority of cases occur on the African continent.
The Ministry of Labor and Health has been informed of “a first human case of clade 1b mpox in the national territory, in Brittany. The recommended management measures have been applied,” details the statement from the Ministry of Health.
Healing between two and four weeks.
Health authorities point out that “there is no need to worry” about the presence of this virus. The Minister responsible for Health, Yannick Neuder, indicated that the infected patient is a “sporadic case.” Supported by the Rennes university hospital, “she has no symptoms and is not in any serious condition,” declared the minister.
Mpox is a viral disease that is transmitted from animals to humans, but is also transmitted through close physical contact with a person infected with the virus.
Regarding the symptoms, Public Health of France specified this Tuesday that “Mpox infection can cause a vesicular rash, formed by fluid-filled vesicles that progress towards desiccation, crusting and then scarring.” The main difference with the variant that will cause the epidemic in 2022 seems to be mainly related to greater transmission and danger.
“This rash may be accompanied by fever, headache, body aches and asthenia. Lymph nodes may be swollen and painful, under the jaw, in the neck or in the groin,” writes SPF.
“Itching may appear. The blisters are concentrated more on the face, in the anogenital area, on the palms of the hands and on the soles of the feet,” continues the health agency.
According to them, “healing occurs in 2 to 4 weeks,” but complications are possible. The virus can cause “digestive problems”, “a significant rash”, “neurological complications” and even “serious forms in the lungs”.
The public most at risk are children, pregnant women and immunocompromised people. “Its fatality rate (mortality) remains generally very low,” explains the health agency.
Source: BFM TV
